Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Return on Sales (2021 - 2023)

Historic Return on Sales for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to 1.19%.

  • Candel Therapeutics' Return on Sales rose 2528400.0% to 1.19% in Q4 2023 from the same period last year, while for Dec 2023 it was 12.99%, marking a year-over-year increase of 2709700.0%. This contributed to the annual value of 14.45% for FY2024, which is 14600.0% down from last year.
  • Per Candel Therapeutics' latest filing, its Return on Sales stood at 1.19% for Q4 2023, which was up 2528400.0% from 13.49% recorded in Q3 2023.
  • Candel Therapeutics' 5-year Return on Sales high stood at 15.65% for Q1 2023, and its period low was 295.52% during Q1 2022.
  • Its 4-year average for Return on Sales is 152.61%, with a median of 171.48% in 2021.
  • Per our database at Business Quant, Candel Therapeutics' Return on Sales tumbled by -1721000bps in 2021 and then skyrocketed by 3111700bps in 2023.
  • Over the past 4 years, Candel Therapeutics' Return on Sales (Quarter) stood at 196.0% in 2020, then decreased by -28bps to 250.03% in 2021, then fell by -2bps to 254.03% in 2022, then skyrocketed by 100bps to 1.19% in 2023.
  • Its last three reported values are 1.19% in Q4 2023, 13.49% for Q3 2023, and 15.17% during Q2 2023.